DSpace Repository

Molecular Characterization of Fungi from Pharmaceutical Products

Show simple item record

dc.contributor.author Otaiku, Eyiowuawi Toluwalase
dc.date.accessioned 2022-06-24T08:47:21Z
dc.date.available 2022-06-24T08:47:21Z
dc.date.issued 2019
dc.identifier.citation Otaiku Eyiowuawi Toluwalase (2019). Molecular Characterization of Fungi from Pharmaceutical Products en_US
dc.identifier.other 15010101013
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/192
dc.description.abstract Studies on Fungi isolated from pharmaceutical products from pharmacy and stores were carried out between the month of April 2019 and July 2019. Collection, isolation, characterization and identification of the isolated Fungi were achieved using both conventional laboratory methods and molecular methods (DNA extraction, PCR and DNA sequencing).Thirteen fungi was isolated out of which seven fungal species were identified and they include Aspergillus tamari strain A, Aspergillus tubingenesis strain, Aspergillus tamari strain B, Aspergillus ellipticus, Aspergillus niger strain A, Aspergillus niger strain B, Aspergillus niger strain C, from the pharmaceutical drugs sampled using 3 protocols. The result of the BLAST DNA sequence database of the isolated fungi revealed that no sequence data was 100% homologous with those in the Gene bank. en_US
dc.language.iso en en_US
dc.publisher Mountain Top University en_US
dc.subject DNA en_US
dc.subject Fungi en_US
dc.title Molecular Characterization of Fungi from Pharmaceutical Products en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account